Last reviewed · How we verify

NCT06369922: TENSUB

TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.

Recruiting now NA Last updated 6 January 2026
What this trial tests

NA trial testing TENS in Stress Incontinence Female in 100 participants. Currently enrolling.

Timeline
1 July 2024
Primary endpoint
31 January 2026
1 June 2027

Quick facts

Lead sponsorUniversity of Rochester
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment100
Start date1 July 2024
Primary completion31 January 2026
Estimated completion1 June 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Rochester

Who can join

18 and older, female only, with Stress Incontinence Female or Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a double-blind randomized control trial in women with stress urinary incontinence who are undergoing an outpatient transurethral bulking procedure for stress urinary incontinence. Subjects will be identified by the University of Rochester urologists and urogynecologists participating in the study who currently oversee stress incontinence care. Subjects will be randomized into two groups. One group will be undergoing the cystoscopy with transcutaneous electrical nerve stimulation (TENS) for analgesia, and the second group will have the cystoscopy with placebo TENS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of TENS

Trials testing the same drug.

Other University of Rochester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06369922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing